Page 61 - Bd News Today

ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced that the first subject has been enrolled in the clinical trial with an FDA-approved IND evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary Liquid Structure™ delivery technology as a potential treatment for Social Anxiety Disorder (SAD).

A man has been taken to hospital following a crash in Geelongs CBD. Emergency services were called to reports someone may have been trapped foll...

CS MEDICA A/S has entered a joint venture with Inner Mongolia RongShi Hi-Tech Co., Ltd regarding production of CS-Medicas CANNASEN® CBD medical products in China and distribution of... | March 26, 2023

Company announces products being available nationwide through Starseed Medicinal Medical Platform...

At the same time, many health care providers believe that patients’ mental health needs are being met.

The Covid-19 pandemic has transformed the way we think of diagnostics in our daily lives. In a recent webinar, BD Vice President for Diagnostics Nikos Pavlidis spoke with a clinician and an epidemiologist where they shared their perspectives on how testing developments have changed the way we track respiratory illnesses.

Santa Clara, CA and Kyoto, Japan, March 20, 2023 (GLOBE NEWSWIRE) -- ROHM Semiconductor today announced that precision power analog company Apex...

More than one-third of people with inflammatory bowel disease report trouble sleeping, with moderate or worse insomnia. And the more severe their insomnia, the worse the disability related to their IBD, a new study finds.

Diagnosed prevalent cases of ulcerative colitis in eight countries will top 2 million in 2031, with the United States having the most cases, according to newly released projections.

Already FDA approved for ulcerative colitis, upadacitinib improves endoscopic response versus placebo in people with Crohns disease, research shows.